Atlassian (TEAM), a provider of productivity software solutions, Wednesday reported 38% revenue growth for the third quarter, with positive contributions from all four business segments. On an IFRS basis, Atlassian’s net loss widened to 85 cents per share from loss of 7 cents per share in the third quarter of fiscal 2018. TEAM stock tanked about 10% in the extended trading hours.
On a non-IFRS basis, net income per share was 21 cents per share for Q3 2019 compared with income per share of 9 cents in the prior year period.
For the fourth quarter of 2019, net loss per share is expected to be about $0.17 on an IFRS basis, and net income per share is expected to be approximately $0.16 on a non-IFRS basis. Revenue is expected to be in the range of $329 million to $331 million.
For the fiscal year 2019, net loss per share is expected to be approximately $1.78 on an IFRS basis, and net income per share is expected to be approximately $0.82 on a non-IFRS basis. Revenue is estimated to be in the range of $1.205 billion to $1.207 billion.
On March 18, 2019, the San Francisco-based tech firm stated that it expects the acquisition of AgileCraft (now Jira Align), which Atlassian acquired for $166 million, to add approximately $1 million to $2 million to fiscal 2019 revenue. Also, the acquisition is expected to reduce IFRS operating margin by approximately one point and reduce non-IFRS operating margin by approximately half a point for fiscal 2019.
With a net new addition of 5,803 customers in the third quarter, Atlassian ended the quarter with a total customer count, on an active subscription or maintenance agreement basis, of 144,038.
Atlassian stock, which closed down 1.58% at $111.19 today, rose 25% since the beginning of this year and jumped 79% in the past 12 months period.
Most Popular
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with
Comments